PUBLISHER: The Business Research Company | PRODUCT CODE: 1810839
PUBLISHER: The Business Research Company | PRODUCT CODE: 1810839
Biologic hernia repair mesh is an implant made from processed human or animal tissues, used to strengthen and support weakened areas during hernia repair surgeries. The mesh is gradually absorbed by the body, encouraging natural tissue regeneration, which makes it particularly suitable for patients at higher risk of infection or those undergoing complex repairs.
The primary types of biologic hernia repair mesh include partially absorbable and fully absorbable meshes. Partially absorbable meshes are composed of both absorbable and non-absorbable materials. Common variants include porcine, bovine, and human dermis meshes, among others. These meshes are distributed through various channels such as direct sales, distributors, online platforms, and pharmacies. They are used in procedures like inguinal, ventral, and umbilical hernia repairs. Key end users include hospitals, ambulatory surgical centers, clinics, and other healthcare facilities.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.
The biologic hernia repair mesh market research report is one of a series of new reports from The Business Research Company that provides biologic hernia repair mesh market statistics, including the biologic hernia repair mesh industry's global market size, regional shares, competitors with the biologic hernia repair mesh market share, detailed biologic hernia repair mesh market segments, market trends and opportunities, and any further data you may need to thrive in the biologic hernia repair mesh market. This biologic hernia repair mesh market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The biologic hernia repair mesh market size has grown strongly in recent years. It will grow from $1.71 billion in 2024 to $1.85 billion in 2025 at a compound annual growth rate (CAGR) of 7.8%. The growth during the historic period can be attributed to several factors, including rising healthcare expenditure, increasing clinical evidence supporting efficacy, higher demand for customized and patient-specific implants, greater adoption in veterinary and pediatric surgeries, and the growing burden of obesity and lifestyle-related disorders.
The biologic hernia repair mesh market size is expected to see strong growth in the next few years. It will grow to $2.46 billion in 2029 at a compound annual growth rate (CAGR) of 7.4%. The growth during the forecast period can be attributed to factors such as the increasing prevalence of hernia cases, higher adoption of advanced biologic implants, a growing geriatric population, rising preference for minimally invasive surgeries, and greater awareness of post-surgical complications. Key trends in the forecast period include advancements in tissue engineering technologies, the development of next-generation biologic scaffolds, improvements in decellularization processes, advancements in bioresorbable material science, and the creation of composite biologic-synthetic meshes.
The increasing prevalence of hernia cases is anticipated to drive the growth of the biologic hernia repair mesh market. Hernias refer to the abnormal protrusion of internal organs or tissues through weakened areas in muscle or connective tissue. The rise in hernia cases is mainly attributed to the growing obesity rates, as excess weight increases pressure on abdominal muscles, raising the risk of hernia formation. Biologic hernia repair mesh is used to treat these cases by providing a scaffold made of natural tissue, which facilitates healing, integrates with the patient's body, and minimizes the chances of rejection or chronic inflammation. For instance, in July 2024, Eurostat reported that inguinal hernia repairs were performed between 142 and 231 times per 100,000 inhabitants in 2022, with Austria having a notably higher rate of 273.2 per 100,000. Therefore, the growing incidence of hernias is contributing to the expansion of the biologic hernia repair mesh market.
Leading companies in the biologic hernia repair mesh market are focusing on the development of innovative solutions, such as reinforced biologic mesh, to improve strength, flexibility, and tissue integration. Reinforced biologic mesh combines biologic tissue with synthetic fibers to enhance durability, support tissue regeneration, and minimize the risk of hernia recurrence. For example, in April 2024, TELA Bio Inc. introduced OviTex inguinal hernia repair (IHR), a reinforced biologic mesh designed for inguinal hernia repair. This mesh is specifically intended for laparoscopic and robotic procedures and uses a combination of biologic ovine extracellular matrix (ECM) and minimal synthetic polymer to deliver strength, support rapid tissue integration, and reduce the risk of complications. It offers advantages such as lower recurrence rates, faster healing, and higher patient satisfaction, addressing the limitations of traditional synthetic meshes.
In February 2024, RTI Surgical Inc., a US-based contract development and manufacturing organization (CDMO), acquired Cook Biotech Inc. for an undisclosed sum. This acquisition allows RTI Surgical to position itself as the only regenerative medicine CDMO capable of providing both allograft and xenograft biomaterials at scale, strengthening its leadership in soft tissue and expanding its market footprint. Cook Biotech Inc. is a US-based company specializing in regenerative medicine, manufactures biologic hernia repair mesh.
Major players in the biologic hernia repair mesh market are Johnson & Johnson, Medtronic plc, Becton Dickinson and Company, DSM Biomedical, Baxter International Inc., W. L. Gore & Associates Inc., Meril Life Sciences, Cook Medical LLC, Integra LifeSciences Corporation, MTF Biologics, LifeCell Corporation, AlloSource, TELA Bio Inc., Kerecis, Assut Europe S.p.A., Serag-Wiessner GmbH & Co. KG, Aroa Biosurgery Limited, ACell Inc., Tissue Regenix Group plc., RTI Surgical Inc., Beijing Datsing Bio-Tech Co. Ltd., and Shanghai Pine & Power Biotech Co. Ltd.
North America was the largest region in the biologic hernia repair mesh market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in biologic hernia repair mesh report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the biologic hernia repair mesh market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The biologic hernia repair mesh market consists of sales of Strattice reconstructive tissue matrix, Surgimend, and Ovitex. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Biologic Hernia Repair Mesh Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on biologic hernia repair mesh market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for biologic hernia repair mesh ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The biologic hernia repair mesh market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.